The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
Welcome,         Profile    Billing    Logout  
 10 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eeles, Rosalind A
BARCODE2, NCT02955082: The BARCODE 2 Study - the Use of Genetic Profiling to Guide Prostate Cancer Treatment

Recruiting
2
450
Europe
Carboplatin, Paraplatin
Institute of Cancer Research, United Kingdom, Royal Marsden NHS Foundation Trust, European Research Council, Imperial College Healthcare NHS Trust, Dartford and Gravesham NHS Foundation Trust, Maidstone & Tunbridge Wells NHS Trust, East and North Hertfordshire NHS Trust, Royal Free Hampstead NHS Trust, Buckinghamshire Healthcare NHS Trust, Barts & The London NHS Trust, Nottingham University Hospitals NHS Trust, Yeovil District Hospital NHS Foundation Trust, Northampton General Hospital NHS Trust
Hormone Refractory Prostate Cancer
09/25
09/25
BARCODE1Pilot, NCT03158922: The BARCODE 1 Pilot Study

Active, not recruiting
N/A
329
Europe
Genetic SNP profiling, Prostate cancer screening, Prostate biopsy, TRUS Biopsy
Institute of Cancer Research, United Kingdom
Prostate Cancer
04/18
12/28
BARCODE 1, NCT03857477: The Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.

Active, not recruiting
N/A
4700
Europe
Genetic SNP profiling, Prostate cancer screening, MRI Scan, MRI, Prostate biopsy, Transperineal Biopsy (TP biopsy)
Institute of Cancer Research, United Kingdom
Prostate Cancer
04/24
12/28
NCT06636526: The I4i PRODICT™ Study: Evaluation of the I4i PRODICT™ Test in Different Ethnic Groups (The I4i PRODICT™ Study).

Not yet recruiting
N/A
1000
Europe
The i4i PRODICT™ test., Prostate cancer screening, MRI Scan, Prostate Biopsy
Institute of Cancer Research, United Kingdom, Royal Marsden NHS Foundation Trust, Imperial College London
Prostate Cancer
12/28
01/33
NCT00261456: The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer

Active, not recruiting
N/A
3500
Europe
PSA test, Prostate Biopsy
Institute of Cancer Research, United Kingdom, Cancer Research UK, Royal Marsden NHS Foundation Trust, Ronald and Rita McAulay Foundation, BRCA Research and Cure Alliance
Prostate Cancer, BRCA Mutation, Mismatch Repair Gene Mutation, Genetic Predisposition to Disease
02/25
02/30
GENPROS, NCT02705846: Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

Recruiting
N/A
4260
Europe
Observation of treatment outcomes via Questionnaire
Institute of Cancer Research, United Kingdom
Prostate Cancer
12/25
12/35
PROFILE, NCT02543905: The Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment

Recruiting
N/A
1050
Europe
Prostate MRI and Biopsy
Institute of Cancer Research, United Kingdom, Royal Marsden NHS Foundation Trust, University of Cambridge, University of Oxford, Queen Mary University of London
Prostate Cancer, Prostate Biopsy, Genetic Counselling, Genetic Markers
12/25
12/25
GENPET, NCT05097274: The Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.

Recruiting
N/A
50
Europe
MRI pelvis or CT imaging under clinical management for Pr Ca, Magnetic resonance imaging or computerized axial tomography, Whole body bone scan imaging, Bone scintigraphy, PET-CT imaging
Institute of Cancer Research, United Kingdom, Cancer Research UK, National Institute for Health Research, United Kingdom
Prostate Cancer, BRCA Mutation, Mismatch Repair Gene Mutation, ATM Gene Mutation, HOXB13 Germline Mutation, CHEK2 Gene Mutation, PALB2 Gene Mutation
12/25
12/30
UKGPCS, NCT01737242: UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies

Active, not recruiting
N/A
23384
Europe
Institute of Cancer Research, United Kingdom, Cancer Research UK, Royal Marsden NHS Foundation Trust
Prostate Cancer
03/24
12/27
AS, NCT05810467: The Active Surveillance Study

Recruiting
N/A
200
Europe
Active Surveillance
Institute of Cancer Research, United Kingdom, Royal Marsden NHS Foundation Trust
Prostate Cancer
12/27
12/27

Download Options